74.26
Solventum Corp stock is traded at $74.26, with a volume of 1.66M.
It is down -0.21% in the last 24 hours and up +7.47% over the past month.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
See More
Previous Close:
$74.42
Open:
$74.79
24h Volume:
1.66M
Relative Volume:
1.20
Market Cap:
$12.86B
Revenue:
$8.28B
Net Income/Loss:
$1.43B
P/E Ratio:
9.0958
EPS:
8.1642
Net Cash Flow:
$-203.00M
1W Performance:
+1.20%
1M Performance:
+7.47%
6M Performance:
-1.85%
1Y Performance:
+1.81%
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SOLV
Solventum Corp
|
74.26 | 12.89B | 8.28B | 1.43B | -203.00M | 8.1642 |
|
ISRG
Intuitive Surgical Inc
|
421.12 | 151.60B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
143.47 | 39.81B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
63.64 | 31.21B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
36.19 | 32.89B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
201.88 | 29.37B | 5.54B | 1.52B | 1.74B | 10.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-24-26 | Initiated | Rothschild & Co Redburn | Sell |
| Jan-26-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-20-26 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
3M Company stock (US88579Y1010): spin-off of Solventum reshapes the Dow veteran - AD HOC NEWS
Wedbush initiates coverage of Solventum (SOLV) with outperform recommendation - MSN
Solventum (NYSE: SOLV) CHRO settles RSUs with tax withholding, updates share stake - Stock Titan
Solventum (SOLV) CFO exercises RSUs and uses 4,404 shares for taxes - Stock Titan
Solventum (SOLV) supply chain chief exercises 3,960 RSUs, 1,678 shares withheld for tax - Stock Titan
Solventum (NYSE: SOLV) CAO vests RSUs; 728 shares withheld for taxes - Stock Titan
Solventum (SOLV) legal chief exercises 4,488 RSUs, with 1,952 shares for tax - Stock Titan
Solventum (SOLV) CEO exercises RSUs, uses 13,503 shares for tax withholding - Stock Titan
Solventum (SOLV) CIO exercises 4,422 RSUs, withholds 2,017 shares for taxes - Stock Titan
3M Company stock (US88579Y1010): spin-off of Solventum reshapes the industrial conglomerate - AD HOC NEWS
3M (MMM) Spin-off Solventum Receives Outperform Rating from Wedb - GuruFocus
Solventum Seen Positioned for Meaningful Re-Rating Over Next 12 to 18 Months, Wedbush Says - marketscreener.com
Wedbush Initiates Solventum at Outperform With $94 Price Target - marketscreener.com
Wedbush initiates Solventum stock coverage at Outperform By Investing.com - Investing.com Australia
Wedbush initiates Solventum stock coverage at Outperform - Investing.com
Solventum’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Solventum’s Next Chapter May Hinge On Shedding Non-Core Units - Finimize
Solventum Stock Tumbles as Tariff Fears Mount - TipRanks
Solventum Foundation and America's ToothFairy Launch National Effort to Expand Access to Preventive Dental Care - PR Newswire
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Why Solventum’s (NYSE:SOLV) Story Deserves Closer Attention? - Kalkine Media
Solventum's (NYSE:SOLV) Solid Earnings May Rest On Weak Foundations - simplywall.st
7-Day Rally Sends Solventum Stock Up 13% - Trefis
Solventum Stock On Fire: Up 13% With 7-Day Winning Streak - Trefis
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum (SOLV) Recently Broke Out Above the 200-Day Moving Average - Yahoo Finance
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Why Solventum (SOLV) Is Up 8.8% After Beating Adjusted Q1 Estimates And Reaffirming 2026 Outlook - Yahoo Finance
Is It Time To Reassess Solventum (SOLV) After Its Recent Share Price Rebound? - Yahoo Finance
Solventum stock is recovering: What's going on? - MSN
Why Solventum (SOLV) is a top momentum stock for the long term - MSN
Why Solventum (SOLV) Is Up 6.4% After Reaffirming 2026 Outlook Despite Softer Q1 Results – And What's Next - simplywall.st
Solventum forecasts annual profit at higher end on wound care demand - MSN
Solventum Q1 FY26 slides: EPS beats forecast, margins expand to 19.5% - Investing.com India
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
Peltz's Trian urges Solventum to rightsize costs, divest non-core businesses - MSN
Earnings call transcript: Solventum Q1 2026 earnings beat expectations - Investing.com UK
Earnings call transcript: Solventum Q1 2026 earnings beat expectations By Investing.com - Investing.com South Africa
Solventum (SOLV) Q1 2026 Earnings Transcript - AOL.com
Solventum (SOLV) tops Q1 earnings and revenue estimates - MSN
Research Alert: CFRA Maintains Hold On Shares Of Solventum Corporation - Moomoo
Solventum executives take the stage at BofA health conference May 13 - Stock Titan
Solventum to Participate in the 2026 BofA Securities Health Care Conference - marketscreener.com
Why Solventum (SOLV) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Wells Fargo Keeps Their Hold Rating on Solventum Corporation (SOLV) - The Globe and Mail
Solventum Bets On 20 Product Launches To Power Post-3M Growth - Citeline News & Insights
Solventum Beats Consensus Estimates for 1Q26 - Medical Device and Diagnostic industry
Solventum (SOLV) Q1 Earnings Slump As Margin Compression Tests Bullish Narratives - simplywall.st
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):